• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿核基质蛋白 22 浓度过高。

Overestimation of nuclear matrix protein 22 in concentrated urine.

机构信息

Center for Prostate Cancer, National Cancer Center, Goyang, Korea.

出版信息

Urology. 2013 Nov;82(5):1059-64. doi: 10.1016/j.urology.2013.05.056. Epub 2013 Sep 14.

DOI:10.1016/j.urology.2013.05.056
PMID:24044907
Abstract

OBJECTIVE

To confirm the hypothesis that nuclear matrix protein 22 (NMP22) is overestimated in concentrated urine, we compared the NMP22 values measured at different dietary states.

METHODS

We retrospectively reviewed 531 healthy subjects who had had abnormal urinary NMP22 values ≥ 10 U/mL at the first test and underwent a second NMP22 test within 2 weeks. The first NMP22 test was performed after overnight fasting, and the second was performed with no dietary restrictions. We compared the NMP22 values between the 2 measurements and investigated the relationship between the NMP22 value and urine specific gravity.

RESULTS

At the second test, 504 subjects (94.9%) had a normal NMP22 value of <10 U/mL and only 27 subjects (5.1%) persistently had an abnormal NMP22 value of ≥ 10 U/mL. Both NMP22 and urine specific gravity at the first test were significantly higher than at the second test (P <.0001). Subjects with an abnormal NMP22 value tended to have a more concentrated urine with a greater urine specific gravity than did the subjects with a normal NMP22 value. This difference was significant in the subgroup undergoing bowel preparation for colonoscopy (P <.001).

CONCLUSION

NMP22 will be overestimated in concentrated urine after overnight fasting. When interpreting the NMP22 value, we should consider the overestimation of NMP22 in concentrated urine.

摘要

目的

为了证实核基质蛋白 22(NMP22)在浓缩尿液中被高估的假说,我们比较了不同饮食状态下测量的 NMP22 值。

方法

我们回顾性分析了 531 例首次检测尿 NMP22 值异常(≥10U/mL)且在 2 周内进行第二次 NMP22 检测的健康受试者。第一次 NMP22 检测在隔夜禁食后进行,第二次检测无饮食限制。我们比较了两次检测的 NMP22 值,并研究了 NMP22 值与尿比重之间的关系。

结果

在第二次检测中,504 例(94.9%)受试者的 NMP22 值<10U/mL 正常,仅 27 例(5.1%)受试者持续存在 NMP22 值≥10U/mL 的异常。第一次检测时的 NMP22 值和尿比重均明显高于第二次检测(P<0.0001)。NMP22 值异常的受试者尿液比重大,尿液浓缩程度高于 NMP22 值正常的受试者。行结肠镜肠道准备的亚组中,这种差异具有统计学意义(P<0.001)。

结论

禁食一夜后,浓缩尿液中的 NMP22 值会被高估。在解释 NMP22 值时,我们应考虑浓缩尿液对 NMP22 值的高估。

相似文献

1
Overestimation of nuclear matrix protein 22 in concentrated urine.尿核基质蛋白 22 浓度过高。
Urology. 2013 Nov;82(5):1059-64. doi: 10.1016/j.urology.2013.05.056. Epub 2013 Sep 14.
2
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.核基质蛋白 22:膀胱癌风险人群的前瞻性评估。UroScreen 研究结果。
BJU Int. 2012 Sep;110(5):699-708. doi: 10.1111/j.1464-410X.2011.10883.x. Epub 2012 Feb 7.
3
Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.尿液细胞学检查、尿核基质蛋白-22及多靶点荧光原位杂交检测法在膀胱癌检测中的敏感性和特异性比较
Scand J Urol Nephrol. 2011 Mar;45(2):113-21. doi: 10.3109/00365599.2010.533694. Epub 2010 Nov 22.
4
NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.核基质蛋白22:一种针对膀胱癌高危患者的敏感且经济高效的检测方法。
Anticancer Res. 1999 Jul-Aug;19(4A):2621-3.
5
Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.尿核基质蛋白22浓度用于膀胱移行细胞癌的诊断。
Urol J. 2008 Fall;5(4):243-7.
6
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].[尿核基质蛋白22(NMP22)作为尿路上皮癌诊断标志物的评估——NMP22作为膀胱癌监测的尿标志物。NMP22研究组]
Gan To Kagaku Ryoho. 1997 May;24(7):829-36.
7
[Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].[尿核基质蛋白22(NMP22)膀胱检测在膀胱癌患者检测中的临床评估]
Hinyokika Kiyo. 2006 Mar;52(3):167-72.
8
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.通过尿核基质蛋白22和细胞学检查对膀胱肿瘤复发、分期及分级进行风险分层。
Eur Urol. 2004 Mar;45(3):304-13; author reply 313. doi: 10.1016/j.eururo.2003.10.020.
9
Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder.尿核基质蛋白22(NMP22)作为膀胱移行细胞癌标志物的效用。
Anticancer Res. 2000 Mar-Apr;20(2B):1169-72.
10
NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.核基质蛋白22检测对于膀胱癌高危患者而言,是一项灵敏且性价比高的检测。
J Urol. 1999 Jan;161(1):62-5.

引用本文的文献

1
The contemporary role and impact of urine-based biomarkers in bladder cancer.尿液生物标志物在膀胱癌中的当代作用及影响
Transl Androl Urol. 2017 Dec;6(6):1031-1042. doi: 10.21037/tau.2017.11.29.
2
The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.核基质蛋白在膀胱癌中关于致癌物环境风险方面的诊断价值
Biomed Res Int. 2017;2017:9643139. doi: 10.1155/2017/9643139. Epub 2017 Aug 8.
3
Urothelial Bladder Cancer Urinary Biomarkers.尿路上皮膀胱癌的尿液生物标志物
EJIFCC. 2014 Apr 28;25(1):99-114. eCollection 2014 Apr.
4
Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.尿细胞学及其他生物标志物对膀胱癌复发和进展的预后价值:一项前瞻性研究。
World J Urol. 2016 Oct;34(10):1405-9. doi: 10.1007/s00345-016-1795-5. Epub 2016 Feb 23.